home Apparatus

J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer

  • Jun 14, 2025

Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China

  • Jun 13, 2025

Car-T From Carvykti, a Good Run Or a Bubble Fest

  • Jun 12, 2025

Inventory Of Fda-Approved Adc Drugs

  • Jun 11, 2025

Fujifilm Ai Technology Can Predict Whether Cognitive Disorders Will Progress To Alzheimer's Disease

  • Jun 10, 2025

Acs Med. Chem. Lett.| Protac-Targeted Jak2 Protein Kinase: a New Approach To Cancer Therapy

  • Jun 09, 2025

Germany Develops Faster, Cheaper New Crown Pcr Assay

  • Jun 08, 2025

Biyze For The Treatment Of Chronic Lymphocytic Leukaemia And Marginal Zone Lymphoma

  • Jun 07, 2025

"New 'Breakthrough' Alzheimer's Drug Approved: Slows Brain Decline By 27%, But $26,500/Year Pricing Controversial

  • Jun 06, 2025

World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us

  • Jun 05, 2025